[HTML][HTML] Antagonizing CDK8 sensitizes colorectal cancer to radiation through potentiating the transcription of e2f1 target gene apaf1

B Chen, P Wen, G Hu, Y Gao, X Qi, K Zhu… - Frontiers in Cell and …, 2020 - frontiersin.org
B Chen, P Wen, G Hu, Y Gao, X Qi, K Zhu, S Chen, L Wu, A Xu, G Zhao
Frontiers in Cell and Developmental Biology, 2020frontiersin.org
Radiotherapy is an essential curative treatment modality for colorectal cancer. Apoptosis is
the major mechanism of IR-induced cell death and aberrant apoptotic signaling results in
radioresistance, which is a hallmark of most, perhaps all, types of human cancers.
Potentiating the induction of apoptosis is an emerging strategy for cancer radiotherapy.
Here, we determined that targeting CDK8 selectively radiosensitized colorectal cancer
through the mitochondria-dependent intrinsic apoptotic signaling, which was mediated …
Radiotherapy is an essential curative treatment modality for colorectal cancer. Apoptosis is the major mechanism of IR-induced cell death and aberrant apoptotic signaling results in radioresistance, which is a hallmark of most, perhaps all, types of human cancers. Potentiating the induction of apoptosis is an emerging strategy for cancer radiotherapy. Here, we determined that targeting CDK8 selectively radiosensitized colorectal cancer through the mitochondria-dependent intrinsic apoptotic signaling, which was mediated through the induction of the transcription of apaf1 that was e2f1- and not p53-dependent. Importantly, the enhanced transcriptional activity of e2f1 was dependent on the kinase activity of CDK8 itself and not on the assembling of the mediator complex. In addition, clinical inhibitor, and in vivo studies confirmed the radiosensitizing effect of CDK8. Our results provide a new targeting strategy to improve the radiotherapy of CRC.
Frontiers